Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R14 | Q9NYV8 | 18/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.66 |
| ▸ | PTGES | O14684 | 2/20 | 0.63 |
| ▸ | TAS2R8 | Q9NYW2 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1278616 | 0.87 | TAS2R14 (1.00) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL1278788 | 0.86 | TAS2R14 (0.97) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL6976163 | 0.84 | TAS2R14 (0.77) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL6300788 | 0.84 | TAS2R14 (0.77) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL3814018 | 0.82 | TAS2R14 (0.73) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL984791 | 0.81 | TAS2R14 (0.71) | TAS2R14MEN1KMT2ACXCR3 | |
| SCHEMBL1279120 | 0.81 | TAS2R14 (1.00) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL1168758 | 0.80 | TAS2R14 (1.00) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL1279324 | 0.80 | TAS2R14 (1.00) | TAS2R14MEN1KMT2ACXCR3PTGES | |
| SCHEMBL1279183 | 0.80 | TAS2R14 (1.00) | TAS2R14MEN1KMT2ACXCR3PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6869968-B1 | Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation | ALLMIRALL PRODESFARMA S.A. (ES) | 2005-03-22 | — | — | US | disclosed |